Changing the face of hepatitis C management - the design and development of sofosbuvir
about
HCV Drug Resistance Challenges in Japan: The Role of Pre-Existing Variants and Emerging Resistant Strains in Direct Acting Antiviral TherapyHepatitis C virus infection: Are there still specific problems with genotype 3?New-Onset Diabetes Mellitus With Exposure to Ledipasvir and SofosbuvirSafety and efficacy of current direct-acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV-TARGET study.Continuum of hepatitis C care in France: A 20-year cohort study.Patch-Clamp Study of Hepatitis C p7 Channels Reveals Genotype-Specific Sensitivity to Inhibitors.Nucleobase but not Sugar Fidelity is Maintained in the Sabin I RNA-Dependent RNA Polymerase.New Viral and Immunological Targets for Hepatitis B Treatment and Cure: A Review.Impact of sustained virologic response on chronic kidney disease progression in hepatitis C.Hepatitis C and renal transplantation in era of new antiviral agents
P2860
Q26782405-E4607A0C-53DD-43B5-86BE-756D4D6283E0Q36269670-6E5264D8-7033-4EBF-ADA9-B2474FD93196Q38703743-5F0CACC7-27E2-4008-80FF-3BA8A683D8E5Q38786027-55144FB8-E32B-4F0B-B961-5AC105656053Q40066639-14CEA990-4751-44DD-A568-C7583EC1223EQ40712261-246E0AC2-C8F3-47B4-AC9C-8E92F35FF7CAQ41169102-2CA4E993-3781-43BE-9CE4-972447DF7879Q47296036-92F97EB5-8F60-482A-9CCE-7E989D4E5CC2Q47550115-97881220-C8C4-4A35-A76A-8C5BD63E8622Q58792851-2B270131-50C2-455C-AE9E-906495FB7F3C
P2860
Changing the face of hepatitis C management - the design and development of sofosbuvir
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Changing the face of hepatitis C management - the design and development of sofosbuvir
@ast
Changing the face of hepatitis C management - the design and development of sofosbuvir
@en
Changing the face of hepatitis C management - the design and development of sofosbuvir
@nl
type
label
Changing the face of hepatitis C management - the design and development of sofosbuvir
@ast
Changing the face of hepatitis C management - the design and development of sofosbuvir
@en
Changing the face of hepatitis C management - the design and development of sofosbuvir
@nl
prefLabel
Changing the face of hepatitis C management - the design and development of sofosbuvir
@ast
Changing the face of hepatitis C management - the design and development of sofosbuvir
@en
Changing the face of hepatitis C management - the design and development of sofosbuvir
@nl
P2093
P2860
P921
P356
P1476
Changing the face of hepatitis C management - the design and development of sofosbuvir
@en
P2093
Andrew Delemos
Bennett Noell
Siddesh Besur
P2860
P304
P356
10.2147/DDDT.S65255
P407
P5008
P577
2015-01-01T00:00:00Z
2015-04-24T00:00:00Z